91 related articles for article (PubMed ID: 7525427)
1. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
[TBL] [Abstract][Full Text] [Related]
2. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
3. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
[TBL] [Abstract][Full Text] [Related]
4. Beta-core fragment of human chorionic gonadotropin in cervical intraepithelial neoplasia (CIN).
Norman RJ; de Medeiros S; Amato F; Davis G; Davy M
Gynecol Oncol; 1993 Apr; 49(1):16-8. PubMed ID: 8482553
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
[TBL] [Abstract][Full Text] [Related]
6. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
7. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH
Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
[TBL] [Abstract][Full Text] [Related]
8. The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses.
Carter PG; Iles RK; Neven P; Davies AP; Shepherd JH; Chard T
Gynecol Oncol; 1993 Dec; 51(3):368-71. PubMed ID: 8112647
[TBL] [Abstract][Full Text] [Related]
9. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
[TBL] [Abstract][Full Text] [Related]
10. UGP in urogenital disorders: Egyptian experience.
el-Ahmady O; Halim AB; Gad M; Walker R
Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
[TBL] [Abstract][Full Text] [Related]
11. Urinary concentrations of beta core fragment of hCG throughout pregnancy.
de Medeiros SF; Amato F; Matthews CD; Norman RJ
Obstet Gynecol; 1992 Aug; 80(2):223-8. PubMed ID: 1378955
[TBL] [Abstract][Full Text] [Related]
12. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
Walker R; Crebbin V; Stern J; Scudder S; Schwartz P
Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
[TBL] [Abstract][Full Text] [Related]
13. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
Rinne K; Shahabi S; Cole L
Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
[TBL] [Abstract][Full Text] [Related]
14. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
Schwartz PE; Cracchiolo BM; Cole LA
Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
[TBL] [Abstract][Full Text] [Related]
16. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
Schwarz-Roeger U; Petzoldt B; Waldschmidt R; Walker RP; Bauknecht T; Kiechle M
Anticancer Res; 1997; 17(4B):3041-5. PubMed ID: 9329597
[TBL] [Abstract][Full Text] [Related]
17. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
[TBL] [Abstract][Full Text] [Related]
18. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
19. Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy.
Hsu JJ; Spencer K; Aitken DA; Crossley J; Choi T; Ozaki M; Tazawa H
Prenat Diagn; 1999 Feb; 19(2):146-58. PubMed ID: 10215073
[TBL] [Abstract][Full Text] [Related]
20. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
Plebani M; Navaglia F; Basso D; De Paoli M; Nicoletto MO; Maraglino E; Torre GC
Anticancer Res; 1996; 16(6B):3833-8. PubMed ID: 9042266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]